Baxter International (NY:BAX)

BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.

October 20, 2025

From Robbins LLP

Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX

October 20, 2025

From DJS Law Group

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM): Grabar Law Office is Investigating Claims on Your Behalf

October 20, 2025

From Grabar Law Office

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX

October 18, 2025

From The Rosen Law Firm PA

Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm

October 17, 2025

From Kirby McInerney LLP

Rosen Law Firm Urges Baxter International Inc. (NYSE: BAX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

October 17, 2025

From The Rosen Law Firm, P.A.

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

October 17, 2025

From Faruqi & Faruqi, LLP

BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm

Peering Into Baxter International Inc's Recent Short Interest ↗

October 17, 2025

Via Benzinga

October 17, 2025

From The Schall Law Firm

Labaton Keller Sucharow LLP Files Securities Class Action Against Baxter International, Inc. and Certain of Its Executives

October 16, 2025

From Labaton Keller Sucharow LLP

Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors

October 15, 2025

From Baxter International Inc.

Shares of healthcare company Baxter International (NYSE:BAX) fell 3% in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President...

Why Baxter (BAX) Stock Is Falling Today

October 10, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Forecasting The Future: 6 Analyst Projections For Baxter Intl ↗

October 07, 2025

Via Benzinga

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

October 06, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.

Topics Stocks

These S&P500 stocks are moving in today's session ↗

October 03, 2025

Via Chartmill

Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)

September 26, 2025

From Baxter International Inc.

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign...

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

Via Benzinga

Topics Economy Government Supply Chain

Why Baxter (BAX) Stock Is Trading Lower Today

September 25, 2025

Shares of healthcare company Baxter International (NYSE:BAX) fell 3.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Topics World Trade

1 Cash-Producing Stock with Solid Fundamentals and 2 We Ignore

September 25, 2025

Baxter has gotten torched over the last six months - since March 2025, its stock price has dropped 32% to $22.86 per share. This was partly driven by its softer quarterly results and might have...

3 Reasons to Avoid BAX and 1 Stock to Buy Instead

September 24, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Topics Government World Trade

3 of Wall Street’s Favorite Stocks That Fall Short

September 17, 2025

Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring

September 16, 2025

From Baxter International Inc.

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.

What's Driving the Market Sentiment Around Baxter Intl? ↗

September 04, 2025

Via Benzinga

Unusual volume S&P500 stocks in Tuesday's session ↗

September 02, 2025

Via Chartmill

S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot ↗

August 26, 2025

The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon.

Via Benzinga

Topics Stocks

Baxter, U.S. Physical Therapy, Cogent, HNI, and TD SYNNEX Stocks Trade Up, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.

Topics Economy

Medical Devices & Supplies - Diversified Stocks Q2 In Review: Baxter (NYSE:BAX) Vs Peers

August 21, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Exploring the top movers within the S&P500 index during today's session. ↗

August 18, 2025

Via Chartmill

BAX Q2 Deep Dive: Margin Pressure and Product Headwinds Temper Near-Term Outlook

August 13, 2025

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter’s revenue...